ClinicalTrials.gg
Drug

Etoricoxib clinical trials

Also written Arcoxia and MK-0663.

studies test it
71
open now
2
in phase 3
18
first study started
2002

How each study uses Etoricoxib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Etoricoxib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Etoricoxib
39
Etoricoxib 60 mg
6
Etoricoxib 90 mg
4
MK0663, etoricoxib
3
Etoricoxib (Treatment Group)
2

Brand

Arcoxia
22
Arcoxia 60 mg
1

Development codes

MK-0663
7

Studies by the year they started

71 studies that test it; most in 2010 (10)

Studies that test Etoricoxib, by start year
YearStudies
20021
20031
20043
20051
20065
20073
20089
20097
201010
201110
20121
20133
20141
20153
20161
20203
20214
20221
20242
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
8
Phase 2
9
Phase 3
18
Phase 4
29
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 48

Organon and Co (15) · Laboratorios Silanes S.A. de C.V. (2) · Karolinska Institutet (2) · Sharif Medical Research Center (1) · Laboratorios Liomont (1) · Rambam Health Care Campus (1) · University of Belgrade (1) · Future University in Egypt (1)

Often tested with

Tested in the same studies.

Celecoxib (4) · Dexamethasone (2) · Duloxetine (1) · Omeprazole (1) · Tramadol (1) · H56 (1) · Ibuprofen (1) · Aceclofenac (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Etoricoxib.

Studies

Open first, then newest update. How each study uses Etoricoxib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 71

See all 71 studies that test Etoricoxib →

Given beside what is tested · 4 — Etoricoxib is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with Etoricoxib

Codes

What other systems call Etoricoxib · ClinicalTrials.gg INT006783

  • MeSH (NLM) D000077613EtoricoxibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) WRX4NFY03RETORICOXIBConfirmed FDA, NLM, Wikidata
  • RxNorm 307296Confirmed FDA, Wikidata
  • Wikidata Q631202etoricoxibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C52188EtoricoxibOne source FDA
  • DrugBank DB01628One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.